is editor-in-chief of The Verge, host of the Decoder podcast, and co-host of The Vergecast. Today, I’m talking with Allan Thygesen, who is the CEO of Docusign. You know Docusign; it’s the platform ...

Docusign will summarize your contracts before you sign to make sure you understand them Businesses can also use AI to speed up preparation and reduce the chances of errors Docusign's AI is also ...

Shares of electronic signature company DocuSign (NASDAQ:DOCU) fell 5.6% in the afternoon session after a wave of competitive anxiety hit the enterprise software sector sparked by a high-profile ...

New AI tools from Docusign aim to make contracts easier to understand and quicker to prepare. For people signing documents like leases or purchases agreements, a new AI feature will make it possible ...

DocuSign (DOCU) reported Q3 revenue of $818.35M and adjusted EPS of $1.01. Both metrics beat expectations. DocuSign generated $262.9M in free cash flow, up 25% year over year. Non-GAAP gross margin ...

DocuSign raised its full-year revenue guidance from a range of $3.189 billion to $3.201 billion to a new range of $3.208 billion to $3.212 billion versus estimates of $3.197 billion, per Benzinga Pro.

Docusign, Inc. (NASDAQ:DOCU) shares rose on Thursday after the company introduced a new way to integrate contract management directly into ChatGPT. • DOCU is in negative territory. Track the action ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Shares of DocuSign dropped this week after OpenAI released a new competitor in the space, DocuGPT. DocuGPT and DocuSign will have many similar capabilities. However, DocuSign has years' worth of ...

Phishing scams are getting smarter, and one of the latest tricks involves fake DocuSign emails that appear to show charges from major companies like Apple. At first glance, these fraud messages look ...

Docusign's recent correction creates a buy opportunity, hinging on cheap valuations and potential growth rebound from IAM product expansion. Growth concerns are valid due to slowing billings and ...